CMS Releases 2025 Medicare Part D Bid

August 7th, 2024

1 min read

2:43

The Centers for Medicare & Medicaid Services (CMS) recently released preliminary technical Medicare Part D bid information for the 2025 contract year to assist Part D plan sponsors in finalizing their Part D and Medicare Advantage (MA) offerings. This preparation is crucial for the upcoming Medicare Open Enrollment period. Additionally, CMS has announced a voluntary demonstration to support the implementation of the redesigned Part D benefit, aiming to improve stability for Medicare beneficiaries in 2025. Preliminary average Part D premiums will be released later this summer, with the finalized 2025 landscape available in mid-to-late September.

The Inflation Reduction Act (IRA), also known as the prescription drug law, introduces several significant improvements to the Part D drug benefit, projected to save Medicare beneficiaries an average of 30% in annual out-of-pocket prescription drug costs by 2025. This will result in a reduction of approximately $7.4 billion in out-of-pocket prescription drug spending for people with Medicare Part D. Key changes include a $2,000 cap on out-of-pocket spending, the elimination of the coverage gap phase ("donut hole"), and the introduction of the Manufacturer Discount Program, which replaces the Coverage Gap Discount Program. The reinsurance payment amount will decrease, with more upfront costs and subsidies shifted to plans.

The base beneficiary premium for 2025 will be $36.78, an increase of $2.08 from 2024. CMS is also conducting a voluntary demonstration to test premium stabilization and revised risk corridors for stand-alone prescription drug plans (PDPs). This demonstration includes a uniform reduction of $15 to the base beneficiary premium, a $35 limit on year-over-year premium increases, and changes to the risk corridors for greater government risk sharing. The demonstration aims to ensure stability and predictability in the Part D market as the IRA changes are implemented.

Overall, these changes shift the government subsidy to Part D plans from reinsurance payments to upfront payments, encouraging better cost management. The national average monthly bid amount for 2025 will be $179.45, reflecting these shifts. CMS aims to provide stability across the Part D market through this demonstration, which is voluntary and open to all stand-alone PDP sponsors.

Source: https://www.cms.gov

View all CMS Inflation Protection Act Press Releases here

Inflation Reduction Act Agent Resource Page

Topics:

CMS

Prescription Drugs

AEP

Inflation Reduction Act

CMS Releases 2025 Medicare Part D Bid

Related Articles

Everything Insurance Agents Need to Know About AHIP Medicare Training 🎓

Consulting Fees on Non-Commissionable Plans: What Insurance Agents Need to Know

Important Update: Changes to the Disaster/Emergency Special Election Period (SEP) for Medicare Plans

The Impact of CY 2026 CMS Policy Changes on Medicare Agents

CMS Contract Year 2026 Policy and Technical Changes to Medicare Advantage and PDP

Comprehensive Agent Guide for Medicare Compliance

2025 Medicare Parts A & B Premiums and Deductibles

Summary of the 2025 Parts A & B Premiums and Deductibles

ACA Marketplace: New CMS Consent Rules

Voice SOA (Scope of Appointment)

Navigating the Rules of Marketing Medicare Plans

New Federal Rule Aims to Eliminate Discrimination in Medigap Plans

HealthSherpa CMS System Changes

Insurance Fraud Accountability Act

New Medicare Guidance on Lowering Prescription Drug Costs

Resource: Educating Clients on the Inflation Reduction Act’s Medicare Reforms

CMS Memo: Definition of Marketing

2024 Medicare Advantage and Part D Final Rule (CMS-4201-F)

New Agent Resource - Medicare 101 Presentation

CMS Proposed Regulations - 2024 MA-PD proposed rule

PSM Guide: Understanding the New CMS Call Recording Changes

Sunfire: Telephony System is LIVE!

4 Racing Tips for the Annual Enrollment Period

Sunfire: Integrated Telephony for Field Agents